Efficacy of Romiplostim In the Treatment and Prevention of Recurrence of Persistent Chemotherapy-Induced Thrombocytopenia By Ogkologos - March 26, 2026 6 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the RECITE study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Teclistamab in Combination with Daratumumab Hyaluronidase-fihj for Relapsed or Refractory Multiple Myeloma ESMO Calls for Cancer Care Integration in EU Global Health Resilience Initiative (GHRI) FX-909 Demonstrates Acceptable Safety and Preliminary Antitumour Activity, Establishing a Proof of Concept for PPARγ Inverse Agonism in Advanced Urothelial Cancer MOST POPULAR Molecular Analysis for Precision Oncology Congress 2025, Paris, France, 15-16 September August 27, 2025 Doctors Say Girl Has ‘Vanishing Bones’ That Are Slowly Disappearing From... May 30, 2019 Patient Guide in Testicular Cancer Now Available Also in German January 14, 2026 The Largest Randomised Study to Date Points to Low Ipsilateral Breast... June 22, 2023 Load more HOT NEWS Six Months Immunogenicity of COVID-19 mRNA-based Vaccine in Patients with Actively... When Caregiving Takes a Toll Making the most of your ‘eureka’ moment: getting from the science... Whole- and Partial-Breast Radiation Effective at Preventing Breast Cancer from Returning
